BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 24265805)

  • 1. Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.
    Akrami R; Jacobsen A; Hoell J; Schultz N; Sander C; Larsson E
    PLoS One; 2013; 8(11):e80306. PubMed ID: 24265805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
    Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
    Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
    Jiang Y; Malouf GG; Zhang J; Zheng X; Chen Y; Thompson EJ; Weinstein JN; Yuan Y; Spano JP; Broaddus R; Tannir NM; Khayat D; Lu KH; Su X
    Oncotarget; 2015 Nov; 6(37):39865-76. PubMed ID: 26431491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer.
    Wang J; Tian Y; Zheng H; Ding Y; Wang X
    Cancer Med; 2019 Jun; 8(6):3026-3035. PubMed ID: 31016892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer.
    White NM; Cabanski CR; Silva-Fisher JM; Dang HX; Govindan R; Maher CA
    Genome Biol; 2014 Aug; 15(8):429. PubMed ID: 25116943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
    Liu X; Gao J; Wang J; Chu J; You J; Jin Z
    Exp Biol Med (Maywood); 2021 Mar; 246(5):547-559. PubMed ID: 33203236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.
    Du Z; Fei T; Verhaak RG; Su Z; Zhang Y; Brown M; Chen Y; Liu XS
    Nat Struct Mol Biol; 2013 Jul; 20(7):908-13. PubMed ID: 23728290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
    Chen Y; Yu X; Xu Y; Shen H
    Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
    Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CCAT1 is overexpressed in endometrial cancer and regulates growth and transcriptome of endometrial adenocarcinoma cells.
    Treeck O; Skrzypczak M; Schüler-Toprak S; Weber F; Ortmann O
    Int J Biochem Cell Biol; 2020 May; 122():105740. PubMed ID: 32173521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer.
    Wang X; Dai C; Ye M; Wang J; Lin W; Li R
    Aging (Albany NY); 2021 Feb; 13(4):5104-5119. PubMed ID: 33534780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.
    Vafaee F; Colvin EK; Mok SC; Howell VM; Samimi G
    Sci Rep; 2017 Sep; 7(1):10374. PubMed ID: 28871211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.
    Wang S; Zhang L; Tao L; Pang L; Fu R; Fu Y; Liang W; Ding Y; Jia W
    Dis Markers; 2020; 2020():9696285. PubMed ID: 32076467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atlas of human long non-coding RNAs with accurate 5' ends.
    Hon CC; Ramilowski JA; Harshbarger J; Bertin N; Rackham OJ; Gough J; Denisenko E; Schmeier S; Poulsen TM; Severin J; Lizio M; Kawaji H; Kasukawa T; Itoh M; Burroughs AM; Noma S; Djebali S; Alam T; Medvedeva YA; Testa AC; Lipovich L; Yip CW; Abugessaisa I; Mendez M; Hasegawa A; Tang D; Lassmann T; Heutink P; Babina M; Wells CA; Kojima S; Nakamura Y; Suzuki H; Daub CO; de Hoon MJ; Arner E; Hayashizaki Y; Carninci P; Forrest AR
    Nature; 2017 Mar; 543(7644):199-204. PubMed ID: 28241135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
    J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer.
    Liu Y; Zhang R; Zhao N; Zhang Q; Yan Z; Chang Z; Wei Y; Wu C; Xu J; Xu Y
    Mol Biosyst; 2016 Oct; 12(10):3176-85. PubMed ID: 27507663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.